Nachawati Law Group Trial Lawyers Renew Commitment to Cancer Victims After Judge’s Rejection of Johnson & Johnson’s Proposed $8.9B Settlement
Trial Lawyers Press on with J&J Litigation, Justice for Cancer Victims
Trial lawyers with
“Our firm respects Judge Kaplan’s decision,” said Nachawati Law Group founder Majed Nachawati, who represents more than 5,000 ovarian cancer victims. “We will continue to push for trial on behalf of each and every one of our clients and engage in resolution discussions with Johnson & Johnson with the goal of reaching a fair settlement that will provide much-needed closure to all our clients.”
According to the lawsuits, J&J failed to warn users of its Johnson’s Baby Powder and Shower-to-Shower products about asbestos contamination and other known risks. Internal records produced by the company show that, for generations, the company has known about links between the products and cancer. All the while, the company heavily advertised and marketed its products to women for feminine hygiene use.
Numerous jury trials have resulted in findings that J&J talc products cause cancer. Verdicts, settlements and legal fees now exceed
J&J has been trying to resolve more than 38,000 cancer lawsuits since 2021. Using a controversial bankruptcy strategy, the corporation sought to shed its verdicts and pending legal liabilities in a shell company known as LTL Management, which immediately filed for bankruptcy protection.
Nachawati Law Group represents individuals in mass tort litigation, businesses and governmental entities in contingent litigation, and individual victims in serious personal injury litigation. For more information, visit www.ntrial.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230731780194/en/
Robert
robert@atwelldesign.com
214-458-4007
Source: Nachawati Law Group